REGN
Regeneron Pharmaceuticals Inc
Price:  
547.36 
USD
Volume:  
456,417.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Regeneron Intrinsic Value

9.50 %
Upside

What is the intrinsic value of Regeneron?

As of 2025-07-04, the Intrinsic Value of Regeneron Pharmaceuticals Inc (REGN) is 599.19 USD. This Regeneron valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 547.36 USD, the upside of Regeneron Pharmaceuticals Inc is 9.50%.

The range of the Intrinsic Value is 437.98 - 999.89 USD

Is Regeneron undervalued or overvalued?

Based on its market price of 547.36 USD and our intrinsic valuation, Regeneron Pharmaceuticals Inc (REGN) is undervalued by 9.50%.

547.36 USD
Stock Price
599.19 USD
Intrinsic Value
Intrinsic Value Details

Regeneron Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) 437.98 - 999.89 599.19 9.5%
DCF (Growth 10y) 527.78 - 1,158.02 710.14 29.7%
DCF (EBITDA 5y) 483.35 - 581.75 529.61 -3.2%
DCF (EBITDA 10y) 567.54 - 729.92 641.90 17.3%
Fair Value 1,041.80 - 1,041.80 1,041.80 90.33%
P/E 510.90 - 563.36 547.42 0.0%
EV/EBITDA 419.61 - 530.39 476.28 -13.0%
EPV 312.68 - 413.38 363.03 -33.7%
DDM - Stable 361.50 - 1,129.45 745.47 36.2%
DDM - Multi 414.25 - 1,022.27 591.49 8.1%

Regeneron Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 59,098.46
Beta 0.72
Outstanding shares (mil) 107.97
Enterprise Value (mil) 58,713.06
Market risk premium 4.60%
Cost of Equity 9.69%
Cost of Debt 4.25%
WACC 9.43%